Company NuVasive, Inc.
Equities
NUVA
US6707041058
Medical Equipment, Supplies & Distribution
Business Summary
Number of employees: 3,000
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | - |
Keith Pfeil
DFI | Director of Finance/CFO | 45 | 31/08/23 |
Ryan Donahoe
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/21 |
Aviva McPherron
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kyle Malone
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/10 |
Investor Relations Contact | - | 09/05/21 | |
Kelly Huller
SEC | Corporate Secretary | 52 | 31/08/23 |
Sean Freeman
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | - |
Keith Pfeil
DFI | Director of Finance/CFO | 45 | 31/08/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 59,324,167 | 52,305,853 ( 88.17 %) | 6,875,000 ( 11.59 %) | 88.17 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
NuVasive Netherlands BV
|
Sector
1st Jan change | Capi. | |
---|---|---|
-3.55% | 186B | |
-2.89% | 107B | |
-4.56% | 67.44B | |
+2.28% | 50.03B | |
+16.80% | 47.81B | |
+4.79% | 41.03B | |
+2.62% | 26.85B | |
+0.67% | 25.82B | |
-0.53% | 25.01B |